Chairs
- Emily Breidbart
- Sowmya Krishnan
BOD Liaison
Laurie Cohen
Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.
New Meds and Tech from PES Drugs and Therapeutics committee
December 16, 2020
Saxenda (Liraglutide) Approved for Adolescent Obesity Prepared by: Laura Page,…
New Meds and Tech from PES Drugs and Therapeutics committee
November 23, 2020
Hydrocortisone Granules (Alkindi Sprinkle) Prepared by: Takara Stanley, Seth Marks…
Drug Alerts and Recalls
October 19, 2020
This content is for PES Members.
Not a member yet? Join the largest Pediatric Endocrine community and unlock a host of tools, resources, and enhance your network! Click here to learn more.